SNY logo

Sanofi (SNY) EBITDA

annual EBITDA:

$10.56B-$3.08B(-22.59%)
December 31, 2024

Summary

  • As of today (May 31, 2025), SNY annual EBITDA is $10.56 billion, with the most recent change of -$3.08 billion (-22.59%) on December 31, 2024.
  • During the last 3 years, SNY annual EBITDA has fallen by -$3.09 billion (-22.63%).
  • SNY annual EBITDA is now -48.28% below its all-time high of $20.42 billion, reached on December 31, 2020.

Performance

SNY EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

quarterly EBITDA:

$2.91B+$2.31B(+385.67%)
March 31, 2025

Summary

  • As of today (May 31, 2025), SNY quarterly EBITDA is $2.91 billion, with the most recent change of +$2.31 billion (+385.67%) on March 31, 2025.
  • Over the past year, SNY quarterly EBITDA has increased by +$886.76 million (+43.73%).
  • SNY quarterly EBITDA is now -72.59% below its all-time high of $10.64 billion, reached on March 31, 2008.

Performance

SNY quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

TTM EBITDA:

$10.68B+$886.76M(+9.05%)
March 31, 2025

Summary

  • As of today (May 31, 2025), SNY TTM EBITDA is $10.68 billion, with the most recent change of +$886.76 million (+9.05%) on March 31, 2025.
  • Over the past year, SNY TTM EBITDA has increased by +$2.43 billion (+29.49%).
  • SNY TTM EBITDA is now -43.95% below its all-time high of $19.06 billion, reached on December 31, 2008.

Performance

SNY TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SNY EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.6%+43.7%+29.5%
3 y3 years-22.6%-9.1%-9.5%
5 y5 years-11.5%+4.6%+64.2%

SNY EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-30.0%at low-37.6%+494.0%-25.6%+32.7%
5 y5-year-48.3%at low-68.9%+494.0%-31.3%+101.6%
alltimeall time-48.3%+721.8%-72.6%+113.4%-44.0%+407.4%

SNY EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.91B(+385.7%)
$10.68B(+9.1%)
Dec 2024
$10.56B(-22.6%)
$600.13M(-87.2%)
$9.80B(+15.8%)
Sep 2024
-
$4.67B(+86.9%)
$8.46B(+5.1%)
Jun 2024
-
$2.50B(+23.2%)
$8.05B(-2.4%)
Mar 2024
-
$2.03B(-374.1%)
$8.25B(-13.8%)
Dec 2023
$13.65B(-9.5%)
-$739.84M(-117.4%)
$9.57B(-33.4%)
Sep 2023
-
$4.26B(+57.9%)
$14.37B(+5.7%)
Jun 2023
-
$2.70B(-19.2%)
$13.59B(+5.1%)
Mar 2023
-
$3.34B(-17.7%)
$12.93B(+1.1%)
Dec 2022
$15.08B(+10.5%)
$4.06B(+16.4%)
$12.79B(+16.7%)
Sep 2022
-
$3.49B(+70.8%)
$10.96B(-4.7%)
Jun 2022
-
$2.04B(-36.3%)
$11.51B(-2.5%)
Mar 2022
-
$3.20B(+43.8%)
$11.80B(+2.1%)
Dec 2021
$13.65B(-33.2%)
$2.23B(-44.7%)
$11.56B(+23.9%)
Sep 2021
-
$4.03B(+72.6%)
$9.33B(+76.0%)
Jun 2021
-
$2.34B(-21.2%)
$5.30B(-57.1%)
Mar 2021
-
$2.97B(-68.4%)
$12.35B(-20.6%)
Dec 2020
$20.42B(+71.1%)
-
-
Jun 2020
-
$9.38B(+236.7%)
$15.55B(+138.9%)
Mar 2020
-
$2.79B(+599.3%)
$6.51B(+8.2%)
Dec 2019
$11.94B(+10.1%)
$398.64M(-86.6%)
$6.01B(-3.4%)
Sep 2019
-
$2.98B(+772.9%)
$6.23B(-11.7%)
Jun 2019
-
$341.51M(-85.1%)
$7.05B(-17.1%)
Mar 2019
-
$2.29B(+274.1%)
$8.51B(+1.6%)
Dec 2018
$10.84B(-0.7%)
$612.69M(-83.9%)
$8.37B(-8.9%)
Sep 2018
-
$3.81B(+112.3%)
$9.19B(+11.4%)
Jun 2018
-
$1.79B(-16.9%)
$8.25B(-3.6%)
Mar 2018
-
$2.16B(+50.4%)
$8.56B(-2.7%)
Dec 2017
$10.91B(-0.4%)
$1.43B(-50.0%)
$8.80B(-7.2%)
Sep 2017
-
$2.87B(+36.2%)
$9.49B(-2.8%)
Jun 2017
-
$2.10B(-12.3%)
$9.76B(-0.5%)
Mar 2017
-
$2.40B(+13.3%)
$9.81B(+6.8%)
Dec 2016
$10.96B(-2.0%)
$2.12B(-32.5%)
$9.19B(+17.6%)
Sep 2016
-
$3.14B(+45.6%)
$7.81B(+3.7%)
Jun 2016
-
$2.15B(+21.3%)
$7.54B(-6.8%)
Mar 2016
-
$1.78B(+139.1%)
$8.09B(-3.5%)
Dec 2015
$11.18B(-11.8%)
$742.91M(-74.0%)
$8.38B(-15.7%)
Sep 2015
-
$2.86B(+5.8%)
$9.94B(-2.6%)
Jun 2015
-
$2.71B(+30.7%)
$10.21B(+0.7%)
Mar 2015
-
$2.07B(-10.1%)
$10.14B(-8.6%)
Dec 2014
$12.68B(-6.3%)
$2.30B(-26.3%)
$11.10B(+1.7%)
Sep 2014
-
$3.13B(+18.7%)
$10.92B(+0.3%)
Jun 2014
-
$2.63B(-13.0%)
$10.89B(+7.0%)
Mar 2014
-
$3.03B(+42.6%)
$10.17B(+0.5%)
Dec 2013
$13.53B
$2.12B(-31.5%)
$10.12B(+5.7%)
Sep 2013
-
$3.10B(+61.5%)
$9.57B(-6.8%)
Jun 2013
-
$1.92B(-35.5%)
$10.27B(-11.0%)
DateAnnualQuarterlyTTM
Mar 2013
-
$2.97B(+88.4%)
$11.53B(-8.5%)
Dec 2012
$14.69B(-8.8%)
$1.58B(-58.4%)
$12.60B(-7.5%)
Sep 2012
-
$3.80B(+19.3%)
$13.63B(-4.8%)
Jun 2012
-
$3.18B(-21.3%)
$14.31B(+12.2%)
Mar 2012
-
$4.04B(+55.1%)
$12.75B(+9.9%)
Dec 2011
$16.11B(+3.3%)
$2.61B(-41.8%)
$11.61B(+2.6%)
Sep 2011
-
$4.48B(+175.4%)
$11.32B(+11.3%)
Jun 2011
-
$1.63B(-43.8%)
$10.17B(-20.1%)
Mar 2011
-
$2.90B(+25.1%)
$12.73B(-8.0%)
Dec 2010
$15.60B(-1.9%)
$2.31B(-30.6%)
$13.83B(-9.3%)
Sep 2010
-
$3.33B(-20.3%)
$15.26B(-2.8%)
Jun 2010
-
$4.18B(+4.4%)
$15.69B(+8.3%)
Mar 2010
-
$4.00B(+7.1%)
$14.49B(+1.1%)
Dec 2009
$15.90B(+3.3%)
$3.74B(-0.7%)
$14.33B(+27.7%)
Sep 2009
-
$3.77B(+26.5%)
$11.22B(-1.9%)
Jun 2009
-
$2.98B(-22.5%)
$11.43B(-6.8%)
Mar 2009
-
$3.84B(+507.9%)
$12.27B(-35.6%)
Dec 2008
$15.38B(+4.2%)
$632.11M(-84.1%)
$19.06B(-679.5%)
Sep 2008
-
$3.98B(+4.3%)
-$3.29B(-242.1%)
Jun 2008
-
$3.82B(-64.1%)
$2.32B(+16.9%)
Mar 2008
-
$10.64B(-149.0%)
$1.98B(+234.8%)
Dec 2007
$14.76B(-3.1%)
-$21.72B(-326.6%)
$591.41M(-61.4%)
Sep 2007
-
$9.59B(+175.5%)
$1.53B(+16.1%)
Jun 2007
-
$3.48B(-62.4%)
$1.32B(+179.2%)
Mar 2007
-
$9.25B(-144.5%)
$472.75M(-113.6%)
Dec 2006
$15.23B(+4.9%)
-$20.78B(-321.7%)
-$3.48B(-125.0%)
Sep 2006
-
$9.37B(+256.0%)
$13.92B(+37.8%)
Jun 2006
-
$2.63B(-50.3%)
$10.10B(-3.7%)
Mar 2006
-
$5.30B(-256.6%)
$10.49B(+0.0%)
Dec 2005
$14.52B(+100.6%)
-$3.38B(-160.9%)
$10.49B(+77.6%)
Sep 2005
-
$5.55B(+83.5%)
$5.91B(-14.1%)
Jun 2005
-
$3.02B(-42.9%)
$6.88B(+42.8%)
Mar 2005
-
$5.30B(-166.5%)
$4.82B(+109.2%)
Dec 2004
$7.24B(+84.8%)
-$7.96B(-222.1%)
$2.30B(-64.4%)
Sep 2004
-
$6.52B(+578.3%)
$6.46B(+143.0%)
Jun 2004
-
$961.72M(-65.4%)
$2.66B(+5.2%)
Mar 2004
-
$2.78B(-173.1%)
$2.53B(+37.9%)
Dec 2003
$3.92B(+38.2%)
-$3.81B(-239.9%)
$1.83B(-31.7%)
Sep 2003
-
$2.72B(+228.0%)
$2.68B(+48.9%)
Jun 2003
-
$829.44M(-60.3%)
$1.80B(+15.1%)
Mar 2003
-
$2.09B(-170.6%)
$1.56B(-399.1%)
Dec 2002
$2.83B(+31.4%)
-$2.96B(-260.7%)
-$523.07M(-121.5%)
Sep 2002
-
$1.84B(+210.2%)
$2.43B(+310.2%)
Jun 2002
-
$593.09M
$593.09M
Dec 2001
$2.16B(+28.4%)
-
-
Dec 2000
$1.68B(+30.7%)
-
-
Dec 1999
$1.29B
-
-

FAQ

  • What is Sanofi annual EBITDA?
  • What is the all time high annual EBITDA for Sanofi?
  • What is Sanofi annual EBITDA year-on-year change?
  • What is Sanofi quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Sanofi?
  • What is Sanofi quarterly EBITDA year-on-year change?
  • What is Sanofi TTM EBITDA?
  • What is the all time high TTM EBITDA for Sanofi?
  • What is Sanofi TTM EBITDA year-on-year change?

What is Sanofi annual EBITDA?

The current annual EBITDA of SNY is $10.56B

What is the all time high annual EBITDA for Sanofi?

Sanofi all-time high annual EBITDA is $20.42B

What is Sanofi annual EBITDA year-on-year change?

Over the past year, SNY annual EBITDA has changed by -$3.08B (-22.59%)

What is Sanofi quarterly EBITDA?

The current quarterly EBITDA of SNY is $2.91B

What is the all time high quarterly EBITDA for Sanofi?

Sanofi all-time high quarterly EBITDA is $10.64B

What is Sanofi quarterly EBITDA year-on-year change?

Over the past year, SNY quarterly EBITDA has changed by +$886.76M (+43.73%)

What is Sanofi TTM EBITDA?

The current TTM EBITDA of SNY is $10.68B

What is the all time high TTM EBITDA for Sanofi?

Sanofi all-time high TTM EBITDA is $19.06B

What is Sanofi TTM EBITDA year-on-year change?

Over the past year, SNY TTM EBITDA has changed by +$2.43B (+29.49%)
On this page